More on ARWR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $88.59 |
|
|||
| Open | $87.99 | ||||
| 52 Wk High | $8.22 | ||||
| 52 Wk Low | $3.07 | ||||
| Day High | $88.25 | ||||
| Day Low | $84.20 | ||||
| P/E | N/A | ||||
| EPS | $-1.30 | ||||
| Volume | 1,282,235 | ||||
- Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
- Form 4 ARROWHEAD PHARMACEUTICAL For: Aug 18 Filed by: OLUKOTUN ADEOYE Y
- Form 4 ARROWHEAD PHARMACEUTICAL For: Aug 18 Filed by: PERRY MICHAEL S
- Form 144 ARROWHEAD PHARMACEUTICAL Filed by: OLUKOTUN ADEOYE Y
- Form 144 ARROWHEAD PHARMACEUTICAL Filed by: PERRY MICHAEL S
- People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
- Form SCHEDULE 13G/A ARROWHEAD PHARMACEUTICAL Filed by: Avoro Capital Advisors LLC
- Arrowhead Pharma (ARWR) PT Raised to $104 at Stifel
- Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
- Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
Entities mentioned with ARWR
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Show More...
